Use of anthrax toxin fusions to stimulate immune responses.
Zarozinski
C C
CC
Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Collier
R J
RJ
Starnbach
M N
MN
D000818:Animals; D000942:Antigens, Bacterial; D019677:Artificial Gene Fusion; D001408:Bacillus anthracis / Q000235:genetics / Q000276:immunology*; D001427:Bacterial Toxins / Q000235:genetics / Q000276:immunology*; D001428:Bacterial Vaccines; D001483:Base Sequence; D003602:Cytotoxicity, Immunologic; D017931:DNA Primers; D000939:Epitopes / Q000235:genetics; D051379:Mice; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction / Q000379:methods; D011993:Recombinant Fusion Proteins / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014614:Vaccines, Synthetic
D000942:Antigens, Bacterial; D001427:Bacterial Toxins; D001428:Bacterial Vaccines; D017931:DNA Primers; D000939:Epitopes; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic; C030325:anthrax toxin